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Objective: To create a multi-site registry to enable future large-scale studies of perinatal depression among
women attending obstetrics clinics in the USA.Methods: A screening and recruitment registry was developed
that included women aged at least 18 years who attended seven obstetric clinics in the University of Michigan
Health System (Ann Arbor, MI, USA) for prenatal care between September 8, 2008, and June 9, 2011. Participants
completed depression screening and research recruitment materials. Results: Of 4745 women who returned a
screening form, 2983 had completed it, giving an overall agreement rate of 62.9%. A total of 630 participants
were enrolled into ten research studies via the registry. Among the 2982 women for whom scores on the
Edinburgh Postnatal Depression Scale were available, 494 (16.6%) fell within the at-risk range or had scores sug-
gestive of clinical depression. Conclusion: The present registry could improve detection of perinatal depression
symptoms and potentially serve as a model for dissemination and implementation at other sites with an interest
in studying factors linked to perinatal depression.
© 2014 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.1. Introduction
Worldwide, major depressive disorder is one of the main causes of
disability-adjusted life years (years of healthy life lost), with women
disproportionately affected [1,2]. The peak prevalence for depressive
disorders among women occurs during the childbearing years [3,4],
with the recorded prevalence as high as 22.2% in pregnancy and the
postpartum period [5,6].
Depression during pregnancy—which has been variously
defined—has been linked to negative birth outcomes [7] and effects on
the infant’s temperament [8]. Prenatal care settings provide an ideal op-
portunity for intervention, but most women who present with symp-
toms of depression at such centers in the USA do not receive adequate
treatment. One study evaluating the ability of US obstetrics clinics to de-
tect symptoms of depression [9] found that just 14% of women with an
elevated score on the Edinburgh Postnatal Depression Scale (EPDS) [10]
were receiving any kind of mental health care, such as antidepressant
medications or psychotherapy.
Therefore, screening for depression has been widely supported as
part of routine obstetric care [11]. Nevertheless, recommendations
published in 2010 by the American College of Obstetricians andy, Miami University, 90 North
7 3073; fax: +1 513 529 2420.
and Obstetrics. Published by Elsevier IGynecologists [12] cautioned that screening alone is insufficient to ad-
dress perinatal depression and that this approach offers potential bene-
fit only when closely linked with appropriate intervention. Systematic
screening is not routinely associated with adequate follow-up and im-
proved clinical outcomes in the USA [13,14]. Furthermore, intervention
research can be limited by difficulties in recruitment. This difficulty
might be related to a lack of coordinated recruitment efforts and/or to
the length of time required to identify a large number of participants
who meet study criteria [15].
Some studies have reported on rates of agreement to participate in
intervention trials amongwomen already screened for perinatal depres-
sion [16,17], but few have recorded rates of agreement to screening pro-
cedures themselves among women attending obstetrics clinics who are
approached to participate in research [18–20]. Consequently, the find-
ings of research studies that target pregnant womenwho are experienc-
ing depression (particularly untreated major depressive disorder) are
often limited by small or homogeneous sample populations [21,22].
The development of screening procedures that are both feasible
within clinic settings and efficient as research recruitment tools is an
important step toward improved screening, detection, and intervention
research. Although many investigators already use screening tools for
research recruitment in obstetrics settings, standardized, multicenter
screening efforts are urgently needed to enable large-scale recruitment
while minimizing the burden on clinical staff and their patients.
Australia, Canada, the UK, and several Scandinavian countries benefitreland Ltd. All rights reserved.
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tries thatmake the process of conducting researchwith large, represen-
tative cohorts easily accessible [23,24]. No such standard registries
currently exist in the USA; guidance on implementation and acceptabil-
ity of such procedures could help to accelerate the pace of US-based re-
search. Importantly, assessing large and diverse samples of patients
attending obstetrics services could allow researchers to characterize
phenotypes of perinatal depression outside of specialty psychiatric care.
The present study aimed to develop a screening and recruitment
registry of women interested in research participation to be used in
obstetric clinics at multiple centers in the USA. The first goalwas to pro-
vide instruction and guidance on optimizing screening and recruitment
registry procedures across multiple settings. The second goal was to
provide data on how the screening process could enhance recruitment
to multiple research studies by streamlining the process to minimize
burden on clinic staff and patients.
2. Materials and methods
A screening and recruitment registry was developed using data pro-
vided bywomenwhoattended oneof seven obstetrics clinicswithin the
University of Michigan Health System (Ann Arbor, MI, USA) between
September 8, 2008, and June 9, 2011. All procedures were approved
by the institutional review board of the University of Michigan
Medical School.
The present study commenced with consultations with obstetrics
clinic stakeholders regarding the feasibility of developing a registry.
Full support for the project was crucial at all stages to ensure that
the registry could be embedded within existing systems (e.g. in
other healthcare screening or during regular prenatal care visits).
The concerns of clinic staff mainly related to the potential time re-
quired to administer screening, return forms to research staff, and
enter additional information (e.g. EPDS score) into medical records.
Therefore, research staff offered a menu of procedures to each clinic
from which to customize registry operations (e.g. options on how to
administer EPDS). Connection with clinical trials was an integral part
of the registry for those agreeing to participate. Additionally, clinics
were aided in referring women to existing mental health services.
Staff members at participating clinics were instructed on EPDS scoring
and interpretation. Clinics were provided with a comprehensive list of
mental health services available to women found to have significant
depressive symptoms.
After consultation, consent forms (to establish willingness to be in-
cluded in the registry) and screening forms (to gather information
about depressive symptoms and other eligibility criteria) were devel-
oped and iteratively updated. Pregnant women aged at least 18 years
who presented for prenatal care at one of the participating obstetrics
clinics were eligible for inclusion in the registry. The consent and
screening forms were attached to the EPDS test administered by clinic
staff. The women were provided with a brief description of the registry
and informed about the need for ongoing research; however, in view of
the changing nature of research within the psychiatry department, a
description of the specific studies recruiting was not provided. They
were also advised that should they be deemed eligible to participate
in a specific study, theywould be contacted by amember of the relevant
research team, that they could decide at that time whether they would
like to participate in a trial, and that no cost would be associated with
such participation. Three options were provided for level of participa-
tion in the registry: (1) complete both the consent and screening
forms to enter the registry and potentially be contacted for participation
in specific research projects (participants); (2) check an “opt out” box
on the consent form to provide anonymous data to the registry only at
the time of screening (anonymous participants); or (c) decline partici-
pation by leaving the consent form blank (refusers).
Version 1 of the screening form was concise and did not require a
separate consent form because it was intended solely to recruit for anexisting project [25] within the University of Michigan Health System,
which had its own consent process. Version 2 included a consent
form and was also longer than version 1 to accommodate inclusion
criteria for additional studies. The final screening form (version 3) was
the shortest because it streamlined the consent and screening forms
and removed items that could easily be found in medical records
(Supplementary Material S1). The consent process allowed for exami-
nation of themedical records to determine eligibility for specific studies.
Two versions of the screening and recruitment system indicated that
psychoeducational materials about perinatal depression could be pro-
vided to women by the research team upon request, and this offer
was made irrespective of participation in the registry.
As noted, three versions of the registry screening form were used to
gather information not found in themedical record. Lifetime depression
and episodes of depression within the past 6 months were assessed
using depression-focused items derived from the Diagnostic Interview
Schedule, Version Three, Revised [26]. The sensitivity of these items to
screen for depression was found to range between 0.83 and 0.94 in a
community sample of adults in three major cities in the USA [27].
Current symptoms of depression were assessed by the EPDS [10]. This
tool is a widely used, reliable, and validated 10-item measure of
perinatal mood symptoms; the EPDS was approved by the obstetrics
clinics participating in the present study as the standard screening
tool to be used for the registry. Total EPDS scores range from 0 to 30,
with high scores indicating increased symptoms of depression [10]. A
score at or above nine indicates a risk of major depressive disorder,
whereas a score at or above 12 indicates that the diagnostic criteria
have probably been met [10].
The EPDSwas scored, reviewed, and entered into themedical record
by a nurse, medical assistant, or obstetrician who addressed the EPDS
results, including indicated risk (e.g. suicide), and provided standard
care, including referral to mental health resources. EPDS and screening
forms were returned to the research staff and data entered into an
SPSS (version 20; IBM, Armonk, NY, USA) tracking database by the reg-
istry coordinatorwhodetermined eligibility for participation in ongoing
clinical research programs; eligible participants were referred to the
relevant investigators for enrollment. The prevalence of depression
symptoms among the registry population was also evaluated as part
of the present study.
Data were analyzed using SPSS version 20 (IBM, Armonk, NY, USA).
Agreement rates were determined by dividing the number of women
who completed the forms by the number eligible to undergo screening.
Frequency data were calculated to describe eligibility for, and participa-
tion in, individual research studies. Themean total EPDS score, frequen-
cy of endorsement of individual EPDS items, history of depression, and
current use of psychotherapy or psychopharmacological treatment
were calculated.
3. Results
A total of 4745 screening forms were collected during the
present study period. The mean age at the time of screening
was 30.3 ± 5.0 years (range 18.0–46.0) and mean gestational age
was 24.2 ± 9.1 weeks (range 0.0–40.0).
Of the women screened, 2259 (47.6%) provided screening data and
agreed to be contacted for potential enrollment in research studies
(participants), 724 (15.3%) declined future contact for research studies
but provided anonymous screening data (anonymous participants),
and 1762 (37.1%) refused to participate under any circumstances.
Thus, 2983 women completed the screening form, giving an overall
agreement rate of 62.9%. Rates of agreement varied over the course of
the present study (Table 1), potentially owing to differences in the
length of the various versions of the registry form. Versions 2 and 3
included an option to receive an information packet about perinatal
depression. However, of the 2535 women who completed these two
versions, only 87 (3.4%) requested the material.
Table 1
Numbers of women who agreed to participate by registry version.a
Registry
version
Agreed to
participateb
Agreed to participate
anonymouslyc
Refused to
participated
Total
1 576 (45.2) 312 (24.5) 385 (30.2) 1273
2 498 (39.5) 317 (25.1) 447 (35.4) 1262
3 1210 (54.8) 191 (8.6) 809 (36.6) 2210
a Values given as number (percentage) or number.
b Gavepermission for both retention of screening data andcontact for research purposes.
c Gave permission for retention of anonymous screening data only.
d Denied permission for both retention of screening data and contact for research
purposes.
Table 3
Endorsement of individual Edinburgh Postnatal Depression Scale items among 1986
women.
Item No. (%)
Not able to laugh or see the funny side of things 397 (20.0)
Not looking forward to things 286 (14.4)
Excessive self-blame 1196 (60.2)
Excessive worry or anxiety 1190 (59.9)
Panic and fear 783 (39.4)
Feeling overwhelmed 1166 (58.7)
Difficulty sleeping owing to mood disturbance 520 (26.2)
Feeling sad or miserable 811 (40.8)
Crying because of sad mood 710 (35.8)
“Hardly ever” or “sometimes” having thoughts of self-harm 80 (4.0)
“Often” having thoughts of self-harm 0
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six intervention trials) used the registry to enroll a total of 630 partici-
pants (mean enrollment 230 women per year). A breakdown of the re-
cruitment process for these studies is provided in Table 2.
Total EPDS scores were available for 2982 women, who had a mean
score of 4.59 ± 4.45 (range 0.0–28.0). Among these women, 2488
(83.4%) had an EPDS score below the recommended cutoff for minimal
depression (b9), 247 (8.3%) had scores within the at-risk range (9–11);
and 247 (8.3%) had scores suggestive of clinical depression (N11). Indi-
vidual EPDS item scores were available for 1986 (79.8%) women. Exces-
sive self-blame, excessive worry or anxiety, and feeling overwhelmed
were the most frequently endorsed items (Table 3).
4. Discussion
The present study developed a screening and recruitment registry
that was effectively implemented in seven clinics in the USA using lim-
ited resources. Overall rate of agreement to registry participation was
high, as was rate of agreement to participate in further research, and
the highest rate of agreement was obtained using a carefully crafted,
concise screening and consent form combination. Furthermore, a high
number of women were successfully enrolled into a range of research
studies utilizing the registry as a recruitment tool.
Positive screening rates observed among the present study partici-
pants (using two cutoff EPDS scores) were consistent with expectations
based on prevalence estimates of major and minor prenatal depression
[5,6]. This finding highlights the importance of increased clinical and
research attention to follow-up of depression screening results, such
as monitoring of appropriate treatment use and outcomes. Few
women requested the psychoeducational materials offered by research
staff. Reasons for declining this material were not solicited, but it is pos-
sible that the women felt that they had received sufficient information
from their doctors and/or did not feel the information would apply to
them at that time.
The overall agreement rate recorded in the present study (62.9%)
was in line with rates reported from other studies in primary careTable 2
Breakdown of the recruitment process among 10 studies that used the perinatal depression re
Study Enrolled Eligible but did not give
permission to be
contacted by research staff
Eligibl
be con
resear
1 (O’Mahen et al. [28])b 12 37 7
2 (Marcus et al. [25])b 6 60 9
3 (Mozurkewich et al. [29])b 70 260 50
4b 13 20 7
5 (Swanson et al. [30])b 52 65 15
6 (Muzik et al. [31]) 69 31 23
7 (Muzik et al. [32])b 1 13 3
8 211 150 1
9 75 80 99
10 121 61 4
a Values are given as number.
b Intervention trial or included a treatment component.settings (53%–87%) [18–20]. However, the rates reported in the previ-
ous investigationswere driven by recruitment to participate in one spe-
cific study rather than several different, unspecified trials as in the
present study. The present strategy of developing a screening and con-
sent registry to facilitate participation inmultiple studies has the poten-
tial to reduce burden on patients, clinic staff, and researchers alike.
Researchers specializing in perinatal mental health who aim to address
the costly and burdensomeoutcomes of depression in the context of ob-
stetrics care might, therefore, benefit from the adoption of an efficient
screening system that allows for streamlined research recruitment
into several related studies simultaneously.
One of the most important lessons learned regarding implementa-
tion of the registry was the need to develop strong and mutually bene-
ficial relationships with obstetrics clinic staff. Several components were
found to be crucial to meeting this objective. First, there was a need for
discussion and communication with all stakeholders to identify mutual
goals. Stakeholders can include, but are not limited to, department
chairs, medical directors, clinic staff (physicians, nurses, medical assis-
tants, officemanagers, and other staff), andmembers of the institutional
review board. Second, a menu of optionswas offered by the researchers
to assist with clinic needs. Such options might include in-service train-
ing, assistancewith themental health referral process, and involvement
of trainees in research. Third, flexible tailoring of screening and recruit-
ment procedures to different clinics while retaining key elements of
standardization helped to accommodate the culture and work flow of
each participating clinic. Finally, regular communication to maintain
an ongoing presence with clinic staff, including in-person visits, was
found to be essential, especially during times of clinic staff turnover.
Another key lesson of the present study involved facilitation of re-
search participation rates. Consent and screening forms underwent sev-
eral modifications to reduce burden on potential participants and to
increase agreement rates, while ensuring a thorough consent process.
A concise consent form was found to be essential to decreasing partici-
pant burden.gistry.a
e but could not
tacted by
ch staff
Not interested in participating
after being contacted by
research staff
Deemed ineligible to
participate after being
contacted by research staff
8 5
5 13
92 147
4 2
8 31
16 493
7 0
1 1
10 7
29 224
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corporated a research recruitment tool into regular clinic operations to
both improve research agreement rates and help to connect patients
with clinical services through participation in trials. Second, the registry
laid out a blueprint for a centralized recruitment core that other
US-based sites could adapt or replicate. Third, the screening and recruit-
ment strategy was found to be acceptable to both clinic staff and many
of the participants. Finally, implementation of the registry facilitated on-
going collaboration among clinicians and researchers from a variety of
disciplines. Such collaboration—coupledwith the ability to reach and re-
cruit large numbers of participants across multiple sites—is likely to be
crucial to the success of future studies that aim to tackle the complex
and multifaceted problem of untreated perinatal depression and its
impact on public health.
Several limitations to the present study should also be considered.
First, the registry represented a process implemented in one hospital
system in the USA. Second, although a considerable age range was re-
corded within the registry population, the mean age of the participants
(30.3 years) was not representative of the typical obstetrics population
in the USA. Finally, the present study lacked systematic data regarding
time or other resources saved as compared with other recruitment
methods. A systematic implementation evaluation, including cost esti-
mates of resources, would add valuable information. Other centers
that develop such a screening program might anticipate using such a
program formore extensive data collection and formulate the screen ac-
cordingly; however, it should be emphasized that short screens tend to
generate high rates of return.
In conclusion, the screening and recruitment registry developed in
the present study has the potential to improve detection of depression
symptoms, increase research recruitment efficiency, reduce time and
patient burden by combining these efforts, and provide a system for cli-
nicians and researchers to work together. Future studies should aim to
replicate themethod at a national level, including collection of common
measures and protocols across health centers to facilitate multicenter
data collection.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ijgo.2014.09.015.
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